BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …

Please cite this paper as: von Hertzen H, Huong N, Piaggio G, Bayalag M, Cabezas E, Fang
A, Gemzell‐Danielsson K, Hinh N, Mittal S, Ng E, Chaturachinda K, Pinter B, Puscasiu L …

Objective The aim of this study was to report on the safety and efficacy of an evidence-based
medical abortion regimen utilizing 200 mg of mifepristone orally followed by home use of …

BACKGROUND: Nonsurgical abortion methods have the potential to improve access to high-
quality abortion care. Until recently, availability and utilization of mifepristone medical …

OBJECTIVE: Mifepristone and oral misoprostol are typically used for medical abortion in
women up to 49 days of gestation, with a 36-to 48-hour interval between the medications …

Objective To compare the efficacy, adverse effects and acceptability of the three most
common misoprostol regimens used with mifepristone for medical abortion. Design …

The aim of this study was to compare the effectiveness, side effects, and acceptability of one-
third the standard dose of mifepristone, ie, 200 mg, and vaginal misoprostol 800 μg to …

This prospective, open-label, randomized trial of healthy adult women up to 9 weeks
pregnant compared mifepristone 200 mg followed 2 days later with misoprostol 400 μg …

Background A wide range of drugs have been studied for first trimester medical abortion.
Studies evaluating different regimens, including combination mifepristone and misoprostol …

OBJECTIVE: To study the efficacy, safety, and acceptability of oral immediately swallowed
and buccal misoprostol 800 mcg after mifepristone 200 mg for terminating pregnancy …